19-17235954-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005234.4(NR2F6):c.485C>T(p.Pro162Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000872 in 1,479,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005234.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR2F6 | NM_005234.4 | c.485C>T | p.Pro162Leu | missense_variant | 3/4 | ENST00000291442.4 | NP_005225.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR2F6 | ENST00000291442.4 | c.485C>T | p.Pro162Leu | missense_variant | 3/4 | 1 | NM_005234.4 | ENSP00000291442.2 | ||
ENSG00000269095 | ENST00000594059.1 | c.125C>T | p.Pro42Leu | missense_variant | 5/5 | 4 | ENSP00000473056.1 | |||
NR2F6 | ENST00000596878.1 | c.125C>T | p.Pro42Leu | missense_variant | 3/3 | 3 | ENSP00000471686.1 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151144Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000338 AC: 3AN: 88706Hom.: 0 AF XY: 0.0000199 AC XY: 1AN XY: 50316
GnomAD4 exome AF: 0.0000934 AC: 124AN: 1328144Hom.: 0 Cov.: 33 AF XY: 0.0000946 AC XY: 62AN XY: 655358
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151144Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73846
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.485C>T (p.P162L) alteration is located in exon 3 (coding exon 3) of the NR2F6 gene. This alteration results from a C to T substitution at nucleotide position 485, causing the proline (P) at amino acid position 162 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at